15289-s-bos

5 83 | Lp(a) and AoVC in FH 22 Kronenberg F, Kuen E, Ritz E, et al. Lipoprotein (a) serum concentrations and apolipoprotein (a) phenotypes in mild and moderate renal failure. Journal of the American Society of Nephrology 2000; 11: 105-15. 23 Hoeg JM, Feuerstein IM, Tucker EE. Detection and q uantitation of calcific atherosclerosis by ultrafast computed tomography in children and young adults with homozygous familial hypercholesterolemia. Arterioscler Thromb 1994; 14: 1066-74. 24 Antonini-Canterin F, Popescu BA, Huang G, et al. Progression of aortic valve sclerosis and aortic valve stenosis: what is the role of statin treatment? Ital Heart J 2005; 6: 119-24. 25 Berglund L, Ramakrishnan R. Lipoprotein(a): an elusive cardiovascular risk factor. Arterioscler Thromb Vasc Biol 2004; 24: 2219-26. 26 Bozbas H, Yildirir A, Atar I, et al. Effects of serum levels of novel atherosclerotic risk factors on aortic valve calcification. The Journal of heart valve disease 2007; 16: 387-93. 27 Versmissen J, Oosterveer DM, Yazdanpanah M, et al. Efficacy of statins in familial hypercholesterolaemia: a long term cohort study. Bmj 2008; 337. 28 Neefjes LA, Ten Kate GJ, Alexia R, et al. Accelerated subclinical coronary atherosclerosis in patients with familial hypercholesterolemia. Atherosclerosis 2011; 219: 721-7. 29 Khera AV, Everett BM, Caulfield MP, Hantash FM, Wohlgemuth J, Ridker PM, Mora S. Lipoprotein(a) concentrations, rosuvastatin therapy, and residual vascular risk: an analysis from the JUPITER Trial (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin). Circulation 2014; 129: 635-42. 30 Kronenberg F, Neyer U, Lhotta K, et al. The Low Molecular Weight Apo (a) Phenotype Is an Independent Predictor for Coronary Artery Disease in Hemodialysis Patients A Prospective Follow-Up. Journal of the American Society of Nephrology 1999; 10: 1027-36. 31 Longenecker JC, Klag MJ, Marcovina SM, et al. High lipoprotein (a) levels and small apolipoprotein (a) size prospectively predict cardiovascular events in dialysis patients. Journal of the American Society of Nephrology 2005; 16: 1794-802. 32 Wexler L, Brundage B, Crouse J, et al. Coronary Artery Calcification: Pathophysiology, Epidemiology, Imaging Methods, and Clinical Implications A Statement for Health Professionals From the American Heart Association. Circulation 1996; 94: 1175-92. 33 Freeman RV, Otto CM. Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation 2005; 111: 3316-26. 34 Demer LL, Tintut Y. Vascular calcification pathobiology of a multifaceted disease. Circulation 2008; 117: 2938-48. 35 Mahabadi AA, Bamberg F, Toepker M, et al. Association of aortic valve calcification to the presence, extent, and composition of coronary artery plaque burden: from the Rule Out Myocardial Infarction using Computer Assisted Tomography (ROMICAT) trial. Am Heart J 2009; 158: 562-8. 36 Koulaouzidis G, Nicoll R, Macarthur T, Jenkins PJ, Henein MY. Coronary artery calcification correlates with the presence and severity of valve calcification. Int J Cardiol 2013. 37 AchenbachS,MoselewskiF,RopersD,etal.Detectionofcalcifiedandnoncalcifiedcoronaryatherosclerotic plaque by contrast-enhanced, submillimeter multidetector spiral computed tomography: a segment- based comparison with intravascular ultrasound. Circulation 2004; 109: 14-7. 38 Shavelle DM, Takasu J, Budoff MJ, Mao S, Zhao XQ, O’Brien KD. HMG CoA reductase inhibitor (statin) and aortic valve calcium. Lancet 2002; 359: 1125-6. 39 Wu B, Elmariah S, Kaplan FS, Cheng G, Mohler ER, 3rd. Paradoxical effects of statins on aortic valve myofibroblasts and osteoblasts: implications for end-stage valvular heart disease. Arterioscler Thromb Vasc Biol 2005; 25: 592-7. 40 Rossebø AB, Pedersen TR, Boman K, et al. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. New England Journal of Medicine 2008; 359: 1343-56. 41 Gilmanov D, Bevilacqua S, Mazzone A, Glauber M. Do statins slow the process of calcification of aortic tissue valves? Interact Cardiovasc Thorac Surg 2010; 11: 297-301. 42 Kronenberg F. Lipoprotein (a) There’s Life in the Old Dog Yet. Circulation 2014; 129: 619-21.